SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is seeing extreme volatility and record volume as the community debates the impact of a lawsuit from Novo Nordisk over its compounded GLP-1 medication and Hims' subsequent withdrawal of the product. Bulls view the steep drop as an oversold buying opportunity, while bears anticipate further declines amid escalating legal and regulatory pressures, especially as Novo Nordisk itself faces an FDA warning regarding its Wegovy ad.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean is trending following its all-stock acquisition of Valaris, a $5.8 billion deal set to create a combined $17 billion offshore drilling industry leader. The community is actively discussing the potential for a strengthened fleet and significant cost savings to capitalize on an emerging upcycle, though some express concerns over shareholder dilution.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies ($PGY) is trending due to a significant market sell-off following its Q4 earnings, where conservative guidance for the coming year overshadowed stronger-than-expected profitability. The community is debating whether this reflects an extreme overreaction to management's focus on prudent risk management or a deeper concern within the AI-powered fintech sector.

monday.com Ltd. engages in the business of operating a cloud-based visual work operating system that consists of modular building blocks that can be easily used and assembled to create software applications and work management tools and serves as a connective layer to integrate with various digital tools across an organization. It operates through the following geographical segments: United States, EMEA, United Kingdom, and Rest of the World. The company was founded by Roy Mann, Eran Kampf, and Eran Zinman in 2012 and is headquartered in Tel Aviv, Israel.

Monday.Com Ltd

Monday.com Ltd

Monday.com is trending after issuing weaker-than-expected revenue guidance for the current quarter and fiscal year, despite a strong earnings beat, intensifying investor concerns that AI is disrupting the traditional software business model. The community is sharply divided, with many viewing the steep selloff as an overreaction and a buying opportunity given the company's cash position, while others remain cautious about AI's long-term impact on the SaaS sector.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending due to a striking disconnect between recent strong earnings, profitability, and a $500M share buyback, and an unprecedented streak of red daily candles pushing the stock to historic lows. Community sentiment is fiercely divided on whether this presents a generational buying opportunity fueled by its AI/AR smartglasses vision and a potential short squeeze, or if persistent management issues will continue to suppress its value.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl (KD) is plummeting amid news of its CFO and General Counsel's departure, delayed financial filings, a reduced 2026 revenue outlook, and an SEC probe into accounting, sparking a community debate between dip-buyers who see an overreaction and others fearing deeper governance issues.

Tokenized asset from Ondo Finance representing BigBear.ai Holdings (Ondo Tokenized).

BigBear.ai Holdings (Ondo Tokenized Stocks)

BigBear.ai Holdings (Ondo Tokenized Stocks) is trending as the community actively discovers and discusses this tokenized asset, prompting questions about its existence, the broader implications of such financial instruments, and its potential relationship to the underlying NYSE-listed BBAI stock.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio (RGNX) is trending due to a clinical hold placed on its RGX-121 and RGX-111 gene therapy programs following a potential tumor link with the AAV vector, just days before RGX-121's critical PDUFA date. The community is intensely debating whether an imminent Complete Response Letter or a delay is inevitable, with many expecting significant downside, while others highlight the company's other pipeline assets as the true value drivers.

Valaris Ltd. engages in the provision of offshore contract drilling services to the international oil and gas industry. It operates through the following segments: Floaters, Jackups, ARO, and Other. The Floaters segment includes drillships and semisubmersible rigs. The Other segment is involved in management services on rigs owned by third-parties and the activities associated with arrangements with ARO under the bareboat charter arrangements. The company was founded in 1975 and is headquartered in Hamilton, Bermuda.

Valaris Ltd

Valaris is trending following its all-stock acquisition by Transocean, a deal prompting active community discussions about the future of offshore drilling and the treatment of Valaris's warrants, alongside strong recent contract awards that bolster its long-term backlog.

Elastic NV is a data analytics company, which engages in the provision of open-source search and analytics engine services. It operates through the United States, the Netherlands, United Kingdom, India, and Rest of World geographical segments. The company was founded by Shay Banon, Uri Boness, Steven Schuurman, and Simon Willnauer on February 9, 2012 and is headquartered in San Francisco, CA.

Elastic N.V

Elastic (ESTC) is seeing intense discussion after strong financial results and the announcement of a $500 million share repurchase program, signaling confidence in its AI and cloud search platform. The market is weighing numerous analyst upgrades and expanding AI adoption against some community concerns regarding recent guidance and sustained profitability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q Cancer Assays

VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q Cancer Assays VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q Cancer Assays...

Volition Announces Data to Support Use of Nu.Q NETs in New Indication

Volition Announces Data to Support Use of Nu.Q NETs in New Indication Volition Announces Data to Support Use of Nu.Q NETs in New Indication PR Newswire HENDERSON, Nev., Jan. 27, 2026 Nu.Q Biomarker...

Volition Continues to Extend Access to Nu.Q Vet Cancer Test

Volition Continues to Extend Access to Nu.Q Vet Cancer Test Volition Continues to Extend Access to Nu.Q Vet Cancer Test PR Newswire HENDERSON, Nev., Jan. 20, 2026 HENDERSON, Nev., Jan. 20, 2026...

Volition Sponsors Symposium at Veterinary Meeting and Expo

Volition Sponsors Symposium at Veterinary Meeting and Expo Volition Sponsors Symposium at Veterinary Meeting and Expo PR Newswire HENDERSON, Nev., Jan. 16, 2026 HENDERSON, Nev., Jan. 16, 2026...

VolitionRx Secures $2.0 Million in Funding

VolitionRx Secures $2.0 Million in Funding VolitionRx Secures $2.0 Million in Funding PR Newswire HENDERSON, Nev., Jan. 8, 2026 HENDERSON, Nev., Jan. 8, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE...

VolitionRx Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats

VolitionRx Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats VolitionRx Announces Breakthrough Clinical Data for Nu.Q Vet Cancer Test in Cats PR Newswire HENDERSON, Nev., Jan. 8...

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.

VolitionRX Ltd

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

Current Price	$0.2544
Prev Close	$0.246
Open	$0.2467
Dividend Yield	0.00%
50-Day Moving Average	$0.2809
Beta	0.48
Avg. Volume	2.51M
PE Ratio	-1.08

52-Week High	$0.94
52-Week Low	$0.22
Market Capitalization	$32.22M
EPS (Annual)	-$0.3116
Price to Book	-0.78
Revenue Per Employee	$14,511.89
Enterprise Value/EBITDA	N/A

VNRX
VolitionRX Ltd

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest VNRX News

VNRXVolitionRX Ltd